(R)-2-((R)-6,7-dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide

CAS No.: 871224-64-5

Chemical Name:: (R)-2-((R)-6,7-dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide

Synonyms: CS-1665;Almorexant;Act-078573;AlMorexant HCl;Almorexant [inn];almorexant (ACT-078573);ACT-078573;ACT 078573;ACT078573;almorexant (ACT-078573), CID 23727689;2-(6,7-dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide;3,4-Dihydro-6,7-dimethoxy-N-methyl-alpha-phenyl-1-[2-[4-(trifluoromethyl)phenyl]ethyl]-2(1H)-isoquinolineacetamide

CBNumber:: CB61512403

Molecular Formula:: C29H31F3N2O3

Molecular Weight:: 512.56

MOL File:: 871224-64-5.mol

MSDS File:: SDS

Modify Date:: 2024/7/2 8:55:13

Request For Quotation

(R)-2-((R)-6,7-dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide Properties

Boiling point	620.4±55.0 °C(Predicted)
Density	1.205
storage temp.	Desiccate at -20°C
solubility	Soluble in DMSO
form	Powder
pka	15.04±0.46(Predicted)
color	White to off-white

(R)-2-((R)-6,7-dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide Preparation Products And Raw materials

Raw materials

Preparation Products

(R)-2-((R)-6,7-dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide Suppliers

Global( 77)Suppliers

Supplier	Tel	Country	ProdList	Advantage	Inquiry
CLEARSYNTH LABS LTD.	+91-22-45045900	Hyderabad, India	6351	58	Inquiry
BOC Sciences	+1-631-485-4226	United States	19553	58	Inquiry
CONIER CHEM AND PHARMA LIMITED	+8618523575427	China	49392	58	Inquiry
TargetMol Chemicals Inc.	+1-781-999-5354 +1-00000000000	United States	19892	58	Inquiry
Finetech Industry Limited	+86-27-87465837 +8618971612321	China	9640	58	Inquiry
Baoji Guokang Bio-Technology Co., Ltd.	0917-3909592 13892490616	China	9316	58	Inquiry
Guangzhou TongYi biochemistry technology Co.,LTD	+8613073028829	China	2996	58	Inquiry
Alfa Chemistry		United States	24072	58	Inquiry
InvivoChem	+1-708-310-1919 +1-13798911105	United States	6393	58	Inquiry
LEAPCHEM CO., LTD.	+86-852-30606658	China	43348	58	Inquiry

Supplier	Advantage
CLEARSYNTH LABS LTD.	58
BOC Sciences	58
CONIER CHEM AND PHARMA LIMITED	58
TargetMol Chemicals Inc.	58
Finetech Industry Limited	58
Baoji Guokang Bio-Technology Co., Ltd.	58
Guangzhou TongYi biochemistry technology Co.,LTD	58
Alfa Chemistry	58
InvivoChem	58
LEAPCHEM CO., LTD.	58

871224-64-5((R)-2-((R)-6,7-dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide)Related Search:

(R)-(+)-(3,4-Dimethoxy)benzyl-1-phenylethylamine (R)-2-((R)-6,7-dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide Almorexant-13C-d3 NA Almorexant (αS,1S) Isomer

Almorexant-d6

chevron_left

1of2

chevron_right

(R)-2-((R)-6,7-dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide Almorexant 2-(6,7-dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide 3,4-Dihydro-6,7-dimethoxy-N-methyl-alpha-phenyl-1-[2-[4-(trifluoromethyl)phenyl]ethyl]-2(1H)-isoquinolineacetamide (2R)-2-((1S)-6,7-Dimethoxy-1-{2-(4-(trifluoromethyl)phenyl)ethyl}-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide Act-078573 Almorexant [inn] AlMorexant HCl 2(1H)-IsoquinolineacetaMide,3,4-dihydro-6,7-diMethoxy-N-Methyl-a-phenyl-1-[2-[4-(trifluoroMethyl)phenyl]ethyl]-, (aR,1S)- Act-078573 (R)-2-((R)-6,7-dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide 2(1H)-Isoquinolineacetamide, 3,4-dihydro-6,7-dimethoxy-N-methyl-α-phenyl-1-[2-[4-(trifluoromethyl)phenyl]ethyl]-, (αR,1S)- CS-1665 ACT-078573;ACT 078573;ACT078573 almorexant (ACT-078573), CID 23727689 almorexant (ACT-078573) (2R)-2-[(1S)-6,7-DIMETHOXY-1-[2-[4-(TRIFLUOROMETHYL)PHENYL]ETHYL]-3,4-DIHYDRO-1H-ISOQUINOLIN-2-YL]-N-METHYL-2-PHENYLACETAMIDE pancreatic cancer,Orexin Receptor (OX Receptor),Pancreatic ductal adenocarcinoma,Cataplexy,ACT078573,Almorexant,HCRT Receptor,Inhibitor,Apoptosis,GPCR,orexin,Hypocretin Receptor,Ca2+ channels,narcolepsy,Caspase,HPAF-II cells,AsPC-1 cells,Calcium Channel,Ca channels,hypocretin,ACT-078573,inhibit,PDAC 871224-64-5 C29H31F3N2O3 Inhibitors API intermediates